Depression in patients with chronic renal disease - What we know and what we need to know

被引:235
|
作者
Kimmel, PL
机构
[1] NIDDKD, Div Kidney Urol & Hematol Dis, NIH, Bethesda, MD 20892 USA
[2] George Washington Univ, Med Ctr, Dept Med, Div Renal Dis & Hypertens, Washington, DC USA
关键词
depression; chronic kidney disease; prevalence; survival; peritoneal dialysis; hemodialysis; chronic renal insufficiency; compliance; suicide; immune dysfunction; marriage;
D O I
10.1016/S0022-3999(02)00310-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Depression is a common, but underdiagnosed and understudied problem in patients with renal disease. The overlap between symptoms of chronic medical illness and those of depression make for a particularly challenging diagnosis in this illness. The prevalence of depression varies with the diagnostic tool employed. The gold standard for the psychiatric diagnosis is the interview, using DSM-IV TR criteria. Researchers in the field of renal disease have often not distinguished between the diagnosis of major depression and high levels of depressive affect in studies. There are almost no data regarding the magnitude of depression in patients with chronic renal insufficiency, patients treated with peritoneal dialysis, and children with renal disease, compared with adults with end-stage renal disease treated with hemodialysis. The relationships between age, ethnicity, marital status and satisfaction, and perception of quality of life and level of depressive affect and diagnosis of depression, and medical outcomes have not been determined in patients with renal disease. The mediators which may underlie the deleterious effects of depression in patients with renal disease, and their relationship with stage of renal dysfunction have not been delineated. More emphasis must be placed on well-designed treatment studies and survival analyses in these populations, using longitudinal techniques. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:951 / 956
页数:6
相关论文
共 50 条
  • [41] Screening for depression in primary care: What do we still need to know?
    McAlpine, DD
    Wilson, AR
    DEPRESSION AND ANXIETY, 2004, 19 (03) : 137 - 145
  • [42] Clinical Research in Diabetes and Urinary Incontinence: What We Know and Need to Know
    Phelan, Suzanne
    Grodstein, Francine
    Brown, Jeanette S.
    JOURNAL OF UROLOGY, 2009, 182 (06): : S14 - S17
  • [43] Anxiety and Depression: What Do We Know of Neuropeptides?
    Kupcova, Ida
    Danisovic, Lubos
    Grgac, Ivan
    Harsanyi, Stefan
    BEHAVIORAL SCIENCES, 2022, 12 (08)
  • [44] Chronic Urticaria in Africa, What We Know and What We Do Not: A Systematic Review
    Day, Cascia
    Peter, Jonny
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2025, 12 (01)
  • [45] Preserving Residual Renal Function in Dialysis: What We Know
    Patel, Nikunjkumar
    Hu, Susie L.
    SEMINARS IN DIALYSIS, 2015, 28 (03) : 250 - 258
  • [46] Reflecting on the immunopathology of arthritis associated with inflammatory bowel disease: what do we know and what should we know?
    Amarnani, Abhimanyu
    Thakker, Suchi
    Panush, Richard S.
    CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2581 - 2588
  • [47] A Narrative Review on Stress and Itch: What We Know and What We Would Like to Know
    Khalil, Nicole B.
    Coscarella, Giulia
    Dhabhar, Firdaus S.
    Yosipovitch, Gil
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (22)
  • [48] What we know and what we don't know about the treatment of schizoaffective disorder
    Murru, A.
    Pacchiarotti, I.
    Nivoli, A. M. A.
    Grande, I.
    Colom, F.
    Vieta, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 (09) : 680 - 690
  • [49] What we know and what we don't know about catastrophic antiphospholipid syndrome
    Rodriguez-Pinto, Ignasi
    Espinosa, Gerard
    Cervera, Ricard
    RHEUMATOLOGY, 2024, 63 (SI) : SI46 - SI53
  • [50] The Future of Exertional Respiratory Problems What Do We Know About the Total Airway Approach and What Do We Need to Know?
    Olin, J. Tod
    Hull, James H.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2018, 38 (02) : 333 - +